News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
36,759 Results
Type
Article (1625)
Company Profile (7)
Press Release (35127)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (15524)
Career Advice (125)
Deals (2309)
Drug Development (3723)
Employer Resources (1)
FDA (571)
Job Trends (784)
News (21224)
Policy (1142)
Tag
Academia (47)
Accelerated approval (1)
Allergies (7)
Alliances (1227)
ALS (6)
Alzheimer's disease (58)
Antibody-drug conjugate (ADC) (9)
Approvals (613)
Artificial intelligence (6)
Autoimmune disease (4)
Automation (2)
Bankruptcy (5)
Best Places to Work (740)
Biosimilars (4)
Biotechnology (6)
Bladder cancer (8)
Breast cancer (33)
Cancer (215)
Cardiovascular disease (19)
Career advice (123)
Career pathing (1)
CAR-T (7)
Cell therapy (17)
Cervical cancer (2)
Clinical research (3362)
Collaboration (39)
Compensation (14)
COVID-19 (70)
CRISPR (4)
C-suite (7)
Cystic fibrosis (14)
Data (297)
Depression (2)
Diabetes (29)
Diagnostics (291)
Digital health (3)
Drug discovery (6)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (4)
Earnings (14105)
Employer resources (1)
Events (3726)
Executive appointments (6)
FDA (818)
Frontotemporal dementia (2)
Funding (30)
Gene editing (8)
Gene therapy (16)
GLP-1 (36)
Government (91)
Guidances (148)
Healthcare (903)
HIV (2)
IgA nephropathy (11)
Immunology and inflammation (6)
Indications (6)
Infectious disease (85)
Inflammatory bowel disease (5)
Influenza (2)
Intellectual property (7)
Interviews (12)
IPO (1667)
Job creations (91)
Job search strategy (113)
Labor market (3)
Layoffs (12)
Legal (195)
Liver cancer (6)
Longevity (1)
Lung cancer (27)
Lymphoma (25)
Management (1)
Manufacturing (8)
MASH (5)
Medical device (805)
Medtech (807)
Mergers & acquisitions (680)
Metabolic disorders (51)
Multiple sclerosis (6)
Neurodegenerative disease (14)
Neuropsychiatric disorders (3)
Neuroscience (101)
NextGen: Class of 2025 (192)
Non-profit (83)
Now hiring (1)
Obesity (17)
Opinion (3)
Ovarian cancer (4)
Pain (11)
Pancreatic cancer (2)
Parkinson's disease (3)
Patents (10)
Patient recruitment (10)
Peanut (4)
People (1047)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (814)
Phase II (1297)
Phase III (1437)
Pipeline (483)
Policy (1)
Postmarket research (180)
Preclinical (268)
Press Release (1)
Prostate cancer (18)
Radiopharmaceuticals (10)
Rare diseases (32)
Real estate (154)
Regulatory (1010)
Reports (4)
Research institute (50)
Resumes & cover letters (10)
RSV (11)
Schizophrenia (6)
Series A (9)
Series B (5)
Sickle cell disease (8)
Spinal muscular atrophy (11)
Sponsored (1)
Startups (92)
Supply chain (1)
Tariffs (2)
The Weekly (1)
Vaccines (17)
Venture capital (4)
Weight loss (9)
Women's health (2)
Date
Today (2)
Last 7 days (32)
Last 30 days (97)
Last 365 days (2034)
2025 (1531)
2024 (2236)
2023 (2389)
2022 (3550)
2021 (4092)
2020 (3474)
2019 (1831)
2018 (1318)
2017 (1139)
2016 (718)
2015 (1180)
2014 (784)
2013 (418)
2012 (514)
2011 (683)
2010 (642)
Location
Africa (66)
Alabama (9)
Arizona (11)
Asia (2123)
Australia (311)
California (602)
Canada (143)
China (40)
Colorado (29)
Connecticut (19)
Delaware (35)
Europe (4198)
Florida (89)
Georgia (20)
Idaho (3)
Illinois (41)
India (2)
Indiana (32)
Japan (31)
Kansas (3)
Kentucky (2)
Louisiana (6)
Maine (8)
Maryland (79)
Massachusetts (388)
Michigan (17)
Minnesota (38)
Missouri (5)
Montana (2)
Nevada (2)
New Hampshire (5)
New Jersey (209)
New Mexico (1)
New York (168)
North Carolina (54)
Northern California (304)
Ohio (13)
Pennsylvania (143)
Rhode Island (1)
South America (73)
Southern California (249)
Tennessee (5)
Texas (63)
United States (2112)
Utah (16)
Virginia (3)
Washington D.C. (5)
Washington State (45)
Wisconsin (5)
36,759 Results for "105".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kairos Pharma Presents on Phase 2 Trial of ENV-105 in Advanced Prostate Cancer at European Society Medical Oncologists (ESMO) Meeting
October 21, 2025
·
4 min read
Press Releases
Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads
October 16, 2025
·
4 min read
Press Releases
Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer
September 12, 2025
·
5 min read
Press Releases
Kairos Pharma Announces Positive Interim Efficacy Analysis of Phase 2 Trial of ENV105 in Advanced Prostate Cancer with Median Progression Free Survival of Over One Year
September 18, 2025
·
6 min read
Press Releases
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease
July 15, 2025
·
4 min read
Press Releases
Kairos Pharma Announces Positive Safety Results from Phase 2 Trial of ENV-105 in Advanced Prostate Cancer
July 15, 2025
·
4 min read
Press Releases
ImmVira Announces First-in-Human Data of Engineered Exosome MVR-EX105 for Fat Reduction and Muscle Preservation by Topical Application at 2025 Annual Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders
September 10, 2025
·
5 min read
Press Releases
NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%
August 15, 2025
·
16 min read
Press Releases
Kairos Pharma Announces Presentation of New Phase 1 Data on ENV105 Combination Therapy in Non-Small Cell Lung Cancer at the World Lung Cancer Conference September 6-9, 2025
September 4, 2025
·
3 min read
Press Releases
Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock
March 26, 2025
·
4 min read
1 of 3,676
Next
